Active

IKRIS PHARMA INTERNATIONAL

Switched

BE0642608172

Rechtspersoon Private limited company 1 establishment

Rue Zénobe Gramme 39, 4821 Dison Groothandel in farmaceutische en medische artikelen

Active for

10 year, 10 months

Financials

Financial year 2025

Worth noting

  • A loss two years in a row.

Gross margin

€ -7,103

▼ 113% vs 2024

Profit

Caution

€ -10,483

▲ 47% vs 2024

Debts

Low

€ 87,411

▼ 5% vs 2024

IKRIS PHARMA INTERNATIONAL from Dison, company number BE0642608172, closed financial year 2025 with a result of € -10,483 after tax. For that financial year IKRIS PHARMA INTERNATIONAL recorded a gross margin of € -7,103 and equity of € 63,628. Compared with financial year 2024, the result moved from € -19,877 to € -10,483. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.

What happened at IKRIS PHARMA INTERNATIONAL?

What happened at IKRIS PHARMA INTERNATIONAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 10,483. Source: NBB ↗
  • New establishment in Bassenge. KBO
  • Start of the company according to the CBE. KBO

In short

From € 3,926 profit in 2021 to € 10,483 loss in 2025.

Paid € 5,871 in corporate taxes since 2021.

Best year ever: 2022, with € 13,252 profit.

A new publication or filing at IKRIS PHARMA INTERNATIONAL? We notify you, reason included.

Follow IKRIS PHARMA INTERNATIONAL

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Philipp Gertrude Quodbach
Parveen Kurner Sikri
IKRIS PHARMA INTERNATIONAL

Behind IKRIS PHARMA INTERNATIONAL are Philipp Gertrude Quodbach and Parveen Kurner Sikri. The same people are also behind BELDIMED.

See the full network in the app

Directors

According to the 2025 annual accounts

Philipp Gertrude Quodbach

Andere functie

Also active at: BELDIMED

Parveen Kurner Sikri

Andere functie

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Zénobe Gramme 39

4821 Dison

2.248.703.983

Rue Marcel de Brogniez 27 box 1

4690 Bassenge

Active since 3 November 2015

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.

+1 more

Details

Company number
0642.608.172
VAT number
BE 0642.608.172
Registered office
Rue Zénobe Gramme 39, 4821 Dison
Names & denominations
IKRIS PHARMA INTERNATIONAL
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
3 November 2015
Peppol
Active · Active since 10 Mar 2026
Activities · NACE

Groothandel in farmaceutische en medische artikelen

Frequently asked questions

What is the enterprise number of IKRIS PHARMA INTERNATIONAL?
The enterprise number of IKRIS PHARMA INTERNATIONAL is BE0642608172.
What is the address of IKRIS PHARMA INTERNATIONAL?
The registered office of IKRIS PHARMA INTERNATIONAL is located at Rue Zénobe Gramme 39, 4821 Dison.
When was IKRIS PHARMA INTERNATIONAL founded?
IKRIS PHARMA INTERNATIONAL was founded on 3 November 2015.
What is the main activity of IKRIS PHARMA INTERNATIONAL?
The main activity of IKRIS PHARMA INTERNATIONAL is "Groothandel in farmaceutische en medische artikelen" (NACE code 46460).
Does IKRIS PHARMA INTERNATIONAL have a website?
No website is currently known for IKRIS PHARMA INTERNATIONAL.
How much profit did IKRIS PHARMA INTERNATIONAL make in 2025?
IKRIS PHARMA INTERNATIONAL recorded a loss after taxes of € 10,483 in financial year 2025.
What is the revenue of IKRIS PHARMA INTERNATIONAL?
As a small company, IKRIS PHARMA INTERNATIONAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -7,103.
Where can I find the annual accounts of IKRIS PHARMA INTERNATIONAL?
IKRIS PHARMA INTERNATIONAL files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of IKRIS PHARMA INTERNATIONAL?
According to the 2025 annual accounts, the directors of IKRIS PHARMA INTERNATIONAL are: Philipp Gertrude Quodbach, Parveen Kurner Sikri.
Who owns IKRIS PHARMA INTERNATIONAL?
Behind IKRIS PHARMA INTERNATIONAL are Philipp Gertrude Quodbach and Parveen Kurner Sikri. The same people are also behind BELDIMED.